| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
3 companies
Mauro David J is a Chief Medical Officer at RXRX with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 30 sells.
Estimated insider holdings value: $2.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 15,000 | $30.96 | $464,349.91 | -59.1% | -56.0% | -76.3% | |
| Sep 7, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 15,000 | $36.69 | $550,282.55 | -55.2% | -63.4% | -80.0% | |
| Aug 5, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 15,000 | $31.09 | $466,394.22 | -48.7% | -43.0% | -81.0% | |
| Jul 6, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 15,000 | $27.47 | $412,107.04 | -75.5% | +17.1% | -79.6% | |
| Jun 7, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 15,000 | $32.44 | $486,622.35 | -36.3% | +16.8% | -85.2% | |
| May 5, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 15,000 | $40.14 | $602,091.90 | -54.2% | -21.0% | -89.4% | |
| Apr 27, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 25,000 | $35.39 | $884,847.87 | -56.8% | -6.2% | -86.2% | |
| Apr 19, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 25,000 | $30.89 | $772,349.30 | -86.2% | -0.3% | -81.8% | |
| Apr 8, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 9,617 | $38.35 | $368,852.28 | -39.5% | -28.6% | -82.4% | |
| Apr 7, 2021 | PRLD Prelude Therapeutics Inc | Chief Medical Officer | Sale+OE | 15,383 | $39.33 | $605,023.27 | -68.5% | -31.2% | -81.8% |